<DOC>
	<DOCNO>NCT01575418</DOCNO>
	<brief_summary>This double-blinded , randomize , pharmacokinetic safety study 3 rectally apply tenofovir microbicide formulation : vaginal formulation ( VF ) , reduce glycerin vaginal formulation ( RGVF ) , rectal-specific formulation ( RF ) . Nine HIV-negative men enrol . Each participant receive two inpatient dos radiolabeled study product . The first inpatient dose product administer without coital dynamic simulation ( CDS ) , second inpatient dose follow CDS procedure 1-hour post dose instillation radiolabeled autologous semen . There washout period least 11 day dose .</brief_summary>
	<brief_title>An Exploratory Rectal Safety Study Three Tenofovir Gel Formulations</brief_title>
	<detailed_description />
	<mesh_term>Glycerol</mesh_term>
	<mesh_term>Radiopharmaceuticals</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>1 . ≥ Age 18 screen 2 . Willing able communicate English 3 . Willing able provide write informed consent take part study 4 . Willing able provide adequate locator information 5 . Understands agree local STI reporting requirement 6 . Biologically male 7 . HIV1 uninfected screen accord standard DAIDS algorithm 8 . Willingness provide semen sample multiple occasion 9 . Per participant report screening , history consensual RAI least within six month prior screen 10 . Willingness perform simulate RAI CDS device 11 . Willing abstain RAI practice include rectal insertion product include use sexual intercourse ( sex toy ) 48 hour inpatient dose willing refrain ejaculation period 48 hour prior semen collection 12 . Must agree use condom duration study 13 . Must general good health 14 . Must agree participate drug trial 15 . Availability return study visit , bar unforeseen circumstance 1 . Significant colorectal symptom ( ) determine medical history participant selfreport ( include limit presence unresolved injury , infectious inflammatory condition local mucosa , history inflammatory bowel disease , presence symptomatic external hemorrhoid , presence painful anorectal condition would tender manipulation . ) 2 . At screening : participantreported symptom and/or clinical laboratory diagnosis active rectal reproductive tract infection require treatment per current CDC guideline symptomatic urinary tract infection ( UTI ) . Infections require treatment include Chlamydia ( CT ) , gonorrhea ( GC ) , syphilis , active HSV lesion , chancroid , genital sore ulcer , , clinically indicate , genital wart . Note HSV seropositivity active genital lesion exclusion criterion , since treatment require . ( Note : Allow one rescreening document treatment ( 30 day ) case urethral GC/CT identify screen ) 3 . At screening : Positive hepatitis B surface antigen Calculated creatinine clearance le 60 mL/min CockcroftGault formula creatinine clearance mL/min = ( 140 age year ) x ( weight kg ) x ( 1 male ) /72 x ( serum creatinine mg/dL ) Alanine transaminase ( ALT ) and/or aspartate aminotransferase ( AST ) &gt; 2.5× site laboratory ULN 4 . Known allergic reaction methylparaben , propylparaben , sorbic acid , glycerin , glycerol , tenofovir , component test article 5 . Known HIVinfected partner 6 . By participant report enrollment , history excessive daily alcohol use ( define CDC heavy drinking consist average consumption 2 drink per day men ) , frequent binge drinking illicit drug use include injection drug , methamphetamine ( crystal meth ) , heroin , cocaine include crack cocaine , within past 12 month 7 . By participant report , use rectallyadministered medication , rectally administer product contain N9 ( include condom ) , investigational product , and/or systemic immunomodulatory medication within 4 week prior first inpatient visit throughout study participation 8 . History recurrent urticaria 9 . Participants whose whole body ( EDE ) radiation exposure , per investigator 's record and/or participant report , exceed 5000mrem/year 10 . Any condition prior therapy , opinion investigator , would preclude informed consent , make study participation unsafe , make individual unsuitable study unable comply study requirement . Such condition may include , limited , current recent history severe , progressive , uncontrolled substance abuse , renal , hepatic , hematological , gastrointestinal , endocrine , pulmonary , neurological , cerebral disease .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>